USANA Health Sciences Earnings: Here’s Why the Stock is Down Now

  Google+ | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

USANA Health Sciences Inc. (NASDAQ:USNA) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 2%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

USANA Health Sciences Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share increased 42.22% to $1.28 in the quarter versus EPS of $0.90 in the year-earlier quarter.

Revenue: Rose 9.72% to $169.1 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: USANA Health Sciences Inc. reported adjusted EPS income of $1.28 per share. By that measure, the company beat the mean analyst estimate of $1.16. It missed the average revenue estimate of $171.77 million.

Quoting Management: Chief Executive Officer, Dave Wentz, said, “For the first quarter of 2013 USANA again delivered record results in sales and earnings per share. During the quarter, our management team continued to execute our strategic initiatives, which are focused on generating worldwide customer growth, growing our Greater China region, advancing our personalization initiatives, and driving new market expansion.”

Key Stats (on next page)…

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business